Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma

Published:2008-02 Issue:2 Volume:32 Page:353-355
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Breccia Massimo,Martelli Maurizio,Cannella Laura,Russo Eleonora,Finolezzi Erica,Stefanizzi Caterina,Levi Anna,Frustaci Annamaria,Alimena Giuliana

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. The secondary leukemias: challenges and research directions;Smith;J Natl Cancer I,1996

2. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation or acute myeloid leukaemia) on outcome of AML type chemotherapy;Estey;Blood,1997

3. Therapy-related leukaemia and myelodysplastic syndrome: clinical, cytogenetic and prognostic features;Kantarjian;J Clin Oncol,1986

4. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience;Tester;J Clin Oncol,1984

5. Chemotherapy-related, late occurring, Philadelphia chromosome in AML, ALL, and CML. Similar events related to treatment with DNA topoisomerase II inhibitors;Pedersen-Bjergaard;Leukemia,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells;Journal of Liposome Research;2020-03-06

2. Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions;American Journal of Clinical Pathology;2018-07-09

3. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature;Journal of Medical Case Reports;2018-03-11

4. Lymphoproliferative Disorders in Patients with Chronic Myeloid Leukemia: A Single-Center Case Series;Acta Haematologica;2015

5. ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia;International Journal of Hematology;2014-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3